Ono to buy Deciphera for $2.4B, looks to expand cancer pipeline and US footprint
Ono Pharmaceutical said Monday it will pay $2.4 billion to acquire Deciphera Pharmaceuticals for cancer drugs that could generate peak annual sales of more than $1 billion.